New Dimensions Health Fund
Health Care Private Investments
Investment Focus
New Dimensions Health is focused exclusively on making investments of $50-$250 million in healthcare information technology and healthcare services companies. In special situations we do company creation and spin-outs with key strategic partners.
​
Portfolio companies provide technology or service delivery innovations that enhance access to care, improve the healthcare experience, lower costs and improve outcomes for patients.
​
We are a global investor and primarily focused on growing companies with established customers, revenue and product.
​
We partner with entrepreneurs, founders, management and providers to work in alignment toward significant growth. We build new dimensions (business models, markets, geographies) on top of strong platforms and foundations
​
Historical Portfolio
​Active Investments
​
Caris life Sciences (US)
Cyrus Biotech (US)
MDClone (Israel)​
Mobile ODT (Israel)
MyDrNow* (US)
PERA Health* (US)
Sikka Software* (US)
TYTO Care (Israel)
​
​Realized Investments​
Ambra Health* (US - Intelerad)
Augmedix* (US - IPO)
Axial Exchange* (US - Ingage)
Guardant Health (US - IPO)
Health Catalyst (US - IPO)
Hitouch Health* (US - Softbank Singapore)
Invitae (US - IPO)
Javelin Oncology* - (US - Genmab Denmark)
NetMeds (India- Reliance)
Practice Fusion* (US -Allscripts/Veridigm)
Proteus - (US - Otsuka)
TelaDoc (US - IPO)
TigerConnect* (US - Vista Equity Partners)
Treato (Israel - Closed)
​
Innovations designed and built
​
First clinical trial e-data capture system (US - Genzyme)
First EMR for MOH (Singapore)
First drug lot tracking system MOH (China)
Aging in place system for British NHS (UK)
Rural teleheatlh delivery system (Bangladesh)
Rural telehealth diabetes care (Mexico)
Imaging Centers and tele-radiology - (Latin America- Multiple)
Remote monitoring of hospital discharges - (Korea)
* NDH member served as Chair or member of Board of Directors.
​
​
​
About Us
Overview
We bring deep domain expertise in healthcare IT and services on a global basis with outstanding track records as investors and operators. We invest in opportunities where we will materially improve the existing business and provide new dimensions for significant future growth.
​​
We have a team approach with at least two senior partners or advisors working with each portfolio company and believe in full transparency for our investors, portfolio companies and colleagues. ​​
Founder
​​
Steven Yecies is the founder and Managing Partner of NDH Fund. He started and led the private HCIT and services investments at OrbiMed Advisors; built over 40 global e-health businesses at Scient as Founder and GM of the healthcare business unit; was founder, CEO or part of the senior leadership team at seven healthcare start-ups and most recently served as Managing Partner at Kain Capital helping the firm more than double in size during his tenure. He holds an MBA from Harvard University, a JD from UC Berkeley, and an AB from Dartmouth College.
​​
Team
​​
NDH is assembling an outstanding team of colleagues and advisers who have the highest level of skills, experience, teamwork and integrity to create the processes and culture to consistently deliver desired results for patients, providers, portfolio companies, investors and NDH colleagues.
​​
​
​
